source
- Pfizer partners with Sciwind to launch GLP-1 obesity drug Ecnoglutide in ChinaPfizer is entering China's obesity market with a new GLP-1 drug, Ecnoglutide, in partnership with Sciwind Biosciences. The New York-based company secured mainland China licensing rights to the inj…
- Lonza to acquire five Merck KGaA US facilities, more than doubling its US footprintLonza, a Swiss contract development and manufacturing organization, announced it will purchase five U.S. manufacturing sites from Merck KGaA. The transaction is valued in the low‑ to mid‑triple‑di…